You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Funded Biomarker Testing

Find an overview of funded biomarker testing in Ontario. Information listed includes diagnostic, predictive and prognostic markers, as well as a summary of testing sites.

Disponible en anglais seulement. Vous pouvez demander un version française.

Funded Biomarker Testing

2 items

Testing on all sinonasal carcinoma where HPV and EBV have been excluded

Funded Biomarker Disease Site: Head and Neck
Biomarker: SMARCA4, SMARCB1
Testing Method:Immunohistochemistry (IHC)
Testing Site: Hospital for Sick Children (SickKids), William Osler Health System

Testing on all sinonasal carcinoma where HPV and EBV have been excluded, and with retained/equivocal SMARC immunohistochemistry test results.

Funded Biomarker Disease Site: Head and Neck
Biomarker: DEK-AFF2, EWSR1-FLI, EGFR, IDH2, NUTM1, PAX3, PAX7
Testing Method:Sequencing
Testing Site: Hospital for Sick Children (SickKids), University Health Network